BOSTON, Aug 6 (Reuters) - Irish drugmaker Elan Corp PLC said on Thursday it has filed suit against Biogen Idec Inc in a bid to block Biogen from gaining control of the multiple sclerosis drug Tysabri.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results